ArticleFrontiers in nutrition2025
Global burden of lung cancer attributable to metabolic and dietary risk factors: an overview of 3 decades and forecasted trends to 2036.
Article in Frontiers in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Spatiotemporal dynamics of the host-tumor metabolic interface: Implications for precision nutritional oncology.Genes & diseases · 2026Review
- A Disproportionality Analysis of Immune Checkpoint Inhibitors in Combination With Platinum-Based Agents Using the FDA Adverse Event Reporting System Database.Cancer medicine · 2026Article
- Senescence-associated gene signatures predict survival in lung cancer: a multi-cohort analysis.GeroScience · 2026Article
- Non-Small Cell Lung Cancer Patients With Tumors ≤ 2 Cm Are Suitable for Wedge Resection or Segmentectomy: A Real-World Study.Thoracic cancer · 2026Article
- The global cancer crisis: a review of growing burden, deepening inequality and initiatives for prevention and early detection.Ecancermedicalscience · 2026Review
- Association between planetary health diet index and lung cancer risk in 106,542 participants: a prospective cohort study.Frontiers in nutrition · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Lung cancer (LC) is the leading cause of cancer-related burden worldwide. Unhealthy dietary patterns and related metabolic diseases, such as diabetes mellitus (DM), represent critical global public health challenges. Nevertheless, the global burden of LC attributable to metabolic and dietary factors remains uncertain. Methods: This study aims to analyze global burden of LC attributable to metabolic and dietary risk factors, based on the Global Burden of Disease (GBD) 2021, from 1990 to 2021. Additionally, the autoregressive integrated moving average (ARIMA) model was utilized to forecast the disease burden of LC for the upcoming 15-year period. Results: High fasting plasma glucose (HFPG) and Diet low in fruits (DLF) are identified as the sole metabolic and dietary risk factors for LC, respectively, according to GBD 2021. The study findings indicate that a marked increase in the LC burden caused by HFPG, whereas the age-standardized rates (ASRs) of mortality and disability-adjusted life-years (DALYs) attributable to DLF for LC represent a general decline. At the social population index (SDI) regional level, the burden of LC attributable to DLF represents the most rapid increase in low-middle SDI regions, and while, the burden of LC attributable to DLF exhibits the most rapid decline in high-middle SDI regions. Moreover, LC burden attributable to HFPG and DLF in mortality and DALYs is higher among males than females, with sex difference being more pronounced in the elderly. Conclusion: From 1990 to 2021, the burden of LC attributed to HFPG has increased owing to the escalating exposure levels of DM, whereas the burden resulting from DLF has declined. The burden of LC attributable to HFPG and DLF exhibits distinct spatiotemporal patterns and similar gender-age patterns.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.